Owlet, Inc. the pioneer of smart infant monitoring, today announces that Dream Sock™ is now available for families across Australia and New Zealand. Dream Sock recently received approval from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous medical device standards in the region.

Owlet, Inc. 是智能婴儿监控的先驱，今天宣布 Dream Sock™ 现已在澳大利亚和新西兰上市。Dream Sock 最近获得了澳大利亚治疗用品管理局 (TGA) 的批准，符合该地区的严格医疗器械标准。

With this milestone achieved, families can now purchase Dream Sock through Owlet’s local website and select retail partners..

随着这一里程碑的达成，家庭现在可以通过Owlet的本地网站和部分零售合作伙伴购买Dream Sock。

“Bringing Owlet’s TGA-approved pediatric health monitor to Australia and New Zealand represents a meaningful step in our international growth strategy, as parents are actively seeking trusted, medically-validated solutions,” said Jonathan Harris, Owlet’s President and CEO. “We are bringing the clinical-grade monitoring of Dream Sock to ANZ families through both direct-to-consumer and leading specialty retail channels, while also extending Owlet360 subscription services further to support our growing base of customers in the region.”.

“将Owlet的TGA批准的儿科健康监测仪带到澳大利亚和新西兰，是我们国际增长战略中具有重要意义的一步，因为家长们正在积极寻找值得信赖、经过医学验证的解决方案，”Owlet总裁兼首席执行官乔纳森·哈里斯表示。“我们通过直接面向消费者以及领先的 specialty 零售渠道，将Dream Sock的临床级监测技术带给澳新地区的家庭，同时进一步扩展Owlet360订阅服务，以支持该地区不断增长的客户群体。”

Dream Sock is a wearable smart baby monitor designed for infants ages 0-18 months (2.5–13.6 kg). Using advanced, clinically validated technology, Dream Sock tracks key vitals, including pulse rate, oxygen level, and sleep trends. Insights are viewable in real-time through the Owlet Dream App (available via iOS and Android), while both the App and the included Base Station provide notifications if readings fall outside preset ranges.

Dream Sock 是一款专为 0-18 个月（2.5–13.6 公斤）婴儿设计的可穿戴智能监护仪。通过使用先进的、经过临床验证的技术，Dream Sock 能够追踪关键生命体征，包括脉搏率、血氧水平和睡眠趋势。用户可以通过 Owlet Dream 应用程序（支持 iOS 和 Android 系统）实时查看数据，同时应用程序和附带的基站会在读数超出预设范围时发出通知。

Dream Sock combines the reassurance parents want with the medical-grade accuracy they expect, empowering families with the information to make more informed care decisions..

Dream Sock 将父母想要的安心与他们期望的医疗级精确度相结合，为家庭提供信息，助力做出更明智的护理决策。

In conjunction with the Dream Sock launch, Owlet is introducing Owlet360 in Australia and New Zealand, marking the first international rollout of the Company’s subscription service. The Owlet Dream App will continue to provide core pulse rate and oxygen tracking and critical notifications at no cost.

随着Dream Sock的推出，Owlet正在澳大利亚和新西兰推出Owlet360，这标志着公司订阅服务的首次国际推广。Owlet Dream应用程序将继续免费提供核心脉搏率和氧气跟踪以及关键通知。

Owlet360 adds a higher-value experience through personalized guidance, expert-backed resources, and deeper analytics designed to complement Dream Sock’s real-time vitals monitoring. Subscription features include daily sleep reports and expanded trend insights across pulse rate, oxygen, movement, comfort temperature, and room environment metrics.

Owlet360 通过个性化指导、专家支持的资源以及旨在补充 Dream Sock 实时生命体征监测的更深入分析，提升了更高价值的体验。订阅功能包括每日睡眠报告以及跨越脉搏率、血氧、运动、舒适温度和房间环境指标的扩展趋势洞察。

The Owlet360 expansion supports Owlet’s strategy to diversify revenue and increase recurring, higher-margin subscription contribution over time..

Owlet360扩展支持Owlet的策略，以实现收入多样化，并随着时间的推移增加经常性、高利润率的订阅贡献。

Dream Sock and Owlet360 are now available in Australia and New Zealand via Owlet’s ecommerce websites and through select retail partners. Dream Sock can also be paired with the Company’s Cam® 2 and purchased as the Dream Duo™. Families can visit www.owletcare.com or www.owletcare.com.au to purchase, explore features, or learn more about how Dream Sock and Owlet360 work together to support infant well-being..

Dream Sock 和 Owlet360 现已通过 Owlet 的电子商务网站以及部分零售合作伙伴在澳大利亚和新西兰上市。Dream Sock 还可以与公司的 Cam® 2 搭配使用，并作为 Dream Duo™ 购买。家庭可以访问 www.owletcare.com 或 www.owletcare.com.au 进行购买、探索功能，或了解更多关于 Dream Sock 和 Owlet360 如何协同工作以支持婴儿健康的信息。

About Owlet, Inc.

关于Owlet公司

Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child’s well-being, support restful sleep, and provide peace of mind anywhere.

Owlet, Inc.（纽约证券交易所代码：OWLT）是一家领先的儿科健康平台，是全球唯一一家提供经美国FDA认证和国际医学认证的可穿戴儿科监护仪的公司，将医院级别的技术直接带入家庭。我们屡获殊荣的儿科产品和创新软件结合了经过临床测试的监控系统、集成的视频平台以及简单易用的应用程序，为父母提供实时健康信息，帮助他们了解孩子的健康状况、支持安心睡眠，并在任何地方获得安心。

Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children's well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design.

自 2012 年以来，已有超过 250 万父母信赖 Owlet 来监测孩子的健康状况和睡眠。这一广泛的采用推动了全球规模最大的儿科健康与睡眠数据集合之一，助力弥合医院与家庭之间的重要差距的创新。Owlet 通过将先进的医疗技术与用户友好的设计相结合，正在树立儿科健康的新标准。

Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow us on LinkedIn and Instagram for company news and updates..

我们的使命简单而远大：让每个婴儿和每个家庭都能在生活中获得最佳的起点。欲了解更多信息，请访问 www.owletcare.com，并在LinkedIn和Instagram上关注我们，获取公司新闻和更新。

Forward-Looking Statements

前瞻性声明

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s expectations regarding the certification and launch of Dream Sock™ and the introduction of Owlet360™in Australia, New Zealand and other international markets; the availability, adoption and commercial success of Dream Sock and Owlet360; the Company’s ability to expand its international footprint, broaden its product and subscription offerings, diversity revenue streams and increase recurring, higher-margin subscription contribution over time; and the Company’s growth prospects; and potential market reception and competitive positioning.

本新闻稿包含1995年《私人证券诉讼改革法案》（“改革法案”）含义内的前瞻性陈述。本新闻稿中所有不涉及历史事实的陈述均应被视为前瞻性陈述，包括但不限于：关于公司对Dream Sock™认证和推出以及在澳大利亚、新西兰和其他国际市场推出Owlet360™的预期陈述；Dream Sock和Owlet360的可用性、采用率和商业成功；公司扩展其国际足迹、拓宽产品和订阅服务、实现收入来源多样化并随时间推移增加经常性高利润订阅贡献的能力；公司的增长前景；以及潜在市场接受度和竞争定位。

In some cases, you can identify forward-looking statements by terms such as “estimate,” “may,” “believes,” “plans,” “expects,” “anticipates,” “intends,” “goal,” “potential,” “upcoming,” “outlook,” “guidance,” the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words.

在某些情况下，你可以通过“估计”、“可能”、“相信”、“计划”、“预期”、“预见”、“意图”、“目标”、“潜力”、“即将来临”、“展望”、“指导”、其否定形式或类似表达来识别前瞻性陈述，尽管并非所有前瞻性陈述都包含这些标志性词语。

Forward-looking statements are based on the Company’s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act.

前瞻性声明基于公司作出此类声明时的预期，仅在其作出之日有效，并且容易受到多种风险、不确定性和其他因素的影响。对于所有此类前瞻性声明，公司声称享有《改革法案》中包含的前瞻性声明的安全港保护。

The Company’s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements.

公司的实际结果、业绩或成就可能与其前瞻性陈述中明示或暗示的任何未来结果、业绩或成就存在重大差异。

Contacts

联系人

Media Contact:

媒体联系人：

[email protected]

电子邮件地址

Investor Contact:

投资者联系方式：

[email protected]

电子邮件地址

Source: businesswire.com

来源：businesswire.com